KTTA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KTTA shares is 6, representing 2.87% of the company's common stock.

TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in KTTA by -0.75% restricting it's holding to 12.4 thousand shares of worth nearly $4.59K. UBS GROUP AG also lessened -100% of the KTTA shares from its portfolio, reducing its holding to 0 shares of worth -. NAPLES GLOBAL ADVISORS, LLC also shunned KTTA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, NORTHERN TRUST CORP increased its stake in KTTA by 100% in the last quarter. The institutional holder raised its holding to 47.07 thousand shares having worth more than $17.42K. RENAISSANCE TECHNOLOGIES LLC also added 5.3% more shares of KTTA to its portfolio, raising its holding to 32.5 thousand shares of worth $12.00K. JANE STREET GROUP, LLC also increased its KTTA shares holding by 100% which brought its holding to 23.59 thousand shares worth $8.73K.

The insider with the most stakes in KTTA is Camac Partners, LLC , at the company. Additionally, KTTA stock is highly held by Member of 10% owner group Shahinian Eric and director STEINMAN LAWRENCE among others.

Company executives, directors, and other insiders own 23.12% percent of Pasithea Therapeutics Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which KTTA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Pasithea Therapeutics Corp. insiders have bought stock, totalling 0 shares

Around 0 Pasithea Therapeutics Corp. shares are held by insiders, which represents about 23.12% of KTTA stock.

KTTA , Camac Partners, LLC holds the largest portfolio of the company's shares. KTTA shares owned by Camac total nearly 1.79 million.

TOWER RESEARCH CAPITAL LLC (TRC) is the largest institutional owner in KTTA which holds 12.4 thousand shares worth $4.59K or 0.05% of the total KTTA shares outstanding followed by UBS GROUP AG with ownership of 0 shares representing 0% of the KTTA ownership. NAPLES GLOBAL ADVISORS, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KTTA is concerned, it is a stock which is not optionable.

Number of KTTA shares short is 11.58K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.27M shares of KTTA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KTTA has 802.65K shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KTTA is 0.32.